Researchers from the Université de Montréal in Canada have created and verified a new class of DNA-based drug transporters that are 20,000 times smaller than a human hair and could enhance cancer treatment and other diseases.
Optimal Dosing at All Times: A Medical Challenge
Providing and maintaining a therapeutic drug dosage during treatment is one of the most important factors in the successful treatment of disease. Overexposure raises side effects whereas sub-optimal therapeutic exposure decreases effectiveness and often results in drug resistance.
Modern medicine continues to struggle with maintaining the ideal drug concentration level in the blood. Patients must take numerous doses at regular intervals since most drugs degrade quickly, and they frequently forget to do so. The drug concentration in each patient’s blood also varies considerably because each has a unique pharmacokinetic profile.
Alexis Vallée-Bélisle, an Associate Professor of Chemistry at the Université de Montréal and a specialist in bio-inspired nanotechnologies, began to investigate how biological systems control and maintain the concentration of biomolecules after noticing that only about 50% of cancer patients receive the ideal drug dosage during certain chemotherapy.
We have found that living organisms employ protein transporters that are programmed to maintain precise concentration of key molecules such as thyroid hormones, and that the strength of the interaction between these transporters and their molecules dictates the precise concentration of the free molecule.
Alexis Vallée-Bélisle, Associate Professor, Chemistry, Université de Montréal
This simple and direct notion prompted Valléé-Belisle and his research group to create synthetic drug transporters that mimic the natural effect of preserving a precise drug concentration during treatment. Valléé-Belisle holds a Canada Research Chair in bioengineering and bionanotechnology.
Arnaud Desrosiers, a Ph.D. student at UdeM, is the study’s first author. He discovered and created two DNA transporters: one for the antimalarial quinine and the other for the chemical doxorubicin, frequently used to treat leukemia and breast cancer.
He went on to show how these synthetic transporters could be easily set up to deliver and maintain any desired drug concentration.
More interestingly, we also found that these nanotransporters could also be employed as a drug reservoir to prolong the effect of the drug and minimize its dosage during treatment. Another impressive feature of these nanotransporters is that they can be directed to specific parts of the body where the drug is most needed – and that, in principle, should reduce most side effects.
Arnaud Desrosiers, Study First Author and PhD Student, Université de Montréal
Nanotreated Mice: Reduced Cardiotoxicity
The researchers collaborated with Jeanne Leblond-Chain, a pharmacist at the Université de Bordeaux in France, Luc DesGroseillers, a biochemist at the Université de Montréal, Jérémie Berdugo, a pathologist at the Université de Montréal, Céline Fiset, a pharmacist at the Montreal Heart Institute, and Vincent De Guire, a clinical biochemist at the Maisonneuve-Rosemont Hospital, which is affiliated with Université de Montréal, to show the effectiveness of these nanotransporters.
The team found that a particular drug-transporter formulation enables doxorubicin to be kept in circulation and significantly inhibits its diffusion toward important organs like the heart, lungs, and pancreas.
This formulation kept doxorubicin in the blood of mice 18 times longer than usual and minimized cardiotoxicity, keeping the mice healthier as indicated by their normal weight gain.
Vallée-Bélisle stated, “Another great property of our nanotransporters is their high versatility. For now, we have demonstrated the working principle of these nanotransporters for two different drugs. But thanks to the high programmability of DNA and protein chemistries, one can now design these transporters to precisely deliver a wide range of therapeutic molecules.”
He further added, “Additionally, these transporters could also be combined with human-designed liposomic transporters that are now being employed to deliver drugs at various rates.”
A Clinical Study for Blood Cancers?
The scientists are now eager to confirm if their discovery works clinically. They believe their doxorubicin nanotransporter could be useful in treating blood cancers since it is designed to keep the drug in blood circulation as effectively as possible.
“We envision that similar nanotransporters may also be developed to deliver drugs to other specific locations in the body and maximize the presence of the drug at tumor sites. This would drastically improve the efficiency of drugs as well as decrease their side effects.”
The National Science and Engineering Research Council of Canada, the Canada Research Chairs, Les Fonds de recherche du Québec – Nature et technologies, and Le regroupement québécois de research sur la fonction, l’ingénierie et les applications des protéines (PROTEO) provided funding for this study.
News
Omicron subvariant BA.2 replicates faster in brain cells than other strains, study finds
Omicron subvariant BA.2 – which was dominant worldwide early this year, including in Hong Kong – replicates more swiftly than other strains and causes faster programmed cell death in human brains, a new study has found. [...]
Seeding the oceans with iron-rich fertilizer nanoparticles to store excess carbon dioxide
The urgent need to remove excess carbon dioxide from Earth’s environment could include enlisting some of our planet’s smallest inhabitants, according to an international research team led by Michael Hochella of the Department of [...]
Temporary graphene ‘tattoos’ that measure blood pressure
Blood pressure is a key vital sign that provides insight into our cardiovascular health. But blood pressure is typically measured only a few times per year by a clinician—and these measurements might not always [...]
Next Covid-19 Strain May be More Dangerous, Lab Study Shows
A South African laboratory study using Covid-19 samples from an immunosupressed individual over six months showed that the virus evolved to become more pathogenic, indicating that a new variant could cause worse illness than [...]
The Fast-Spreading New COVID-19 Subvariant XBB Is Part of a ‘New Class’ of Omicron
For the past several months, Omicron subvariants BA.4 and BA.5 have dominated COVID-19 cases in the U.S. But now, there’s a class of new COVID subvariants on the rise and one in particular is getting plenty of [...]
Overcoming challenges in the delivery of nucleic acid therapeutics
Nucleic acid therapies involving DNA or RNA have significant potential to treat genetic disorders, infectious diseases, and cancer; however, research suggests that less than 1% of injected nucleic acid doses reach target cells in [...]
FDA approves $3.5 million treatment for hemophilia, now the most expensive drug in the world
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug [...]
Wireless smart bandage promotes faster closure of wounds, enhances skin recovery
Some wounds just won’t heal. Infections, diseases like diabetes, and suppressed immune systems often stack up to slow healing. Chronic wounds can last months and lead to anxiety and depression. In the worst cases, [...]
Using Nanofibers to Guide the Development of Novel Biomaterials
Over the years, researchers have tried hard to comprehend topographic signals that promote cell mechanical sensitive responses. The extracellular matrix (ECM) provides a complex cellular microenvironment that controls cellular behavior. Nevertheless, only a few [...]
Measles now an imminent global threat due to pandemic, say WHO and CDC
There is now an imminent threat of measles spreading in various regions globally, as COVID-19 led to a steady decline in vaccination coverage and weakened surveillance of the disease, the World Health Organization (WHO) [...]
Covid-19: Brain scans show new evidence of what could be causing long Covid
In a recent study, it was shown that people with long Covid have had physical changes to their brains several months after experiencing the initial infection. The study included MRIs of patients who continued [...]
Western University is building Canada’s secret weapon against the next pandemic
Western University in London, Ont., is building a unique research lab to study humanity's greatest viral threats — a secret weapon, if you will, one that it's expected would put Canada and the world in a better position if [...]
Cancer patients test world’s first ‘computer-designed’ antibodies, made in Israel
Cancer patients are testing a medicine made of antibodies that were designed from scratch on a computer in Israel and whose inventor has “programmed” them to “decide” whether cells surrounding tumors are bad or good. [...]
Corrosion-Resistant Superhydrophobic Graphene-Based Coatings on Copper Substrate
In an article published in the journal Scientific Reports, researchers presented the potentiostatic deposition used to electrodeposit nickel (Ni) and nickel-graphene (Ni-G) films on copper substrates. Myristic acid (MA) was employed to alter the plane of the [...]
A chip to replace animal testing
New drugs made from nanoparticles that can easily penetrate any interface within our bodies are a great hope in medicine. For such hopefuls to reach the market, their safety must be ensured. In this [...]
Researchers develop new, heat-efficient nanoparticles for treating cancer
Oregon State University scientists have invented a way to make magnetic nanoparticles that get hotter than any previous nanoparticle, improving their cancer fighting ability. Faculty from the OSU College of Pharmacy spearheaded a collaboration [...]
